{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:05:38Z","timestamp":1780347938108,"version":"3.54.1"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>The SARS-CoV-2 virus has taken more than 2 million lives on a global scale. Over 10 million people were confirmed with COVID-19 infection. The well-known spot of primary infection includes the lungs and the respiratory system. Recently it has been reported that the cardiovascular system and coagulation mechanisms were the second major targets of biological system affected due to the viral replication. The replication mechanism of SARS-CoV-2 involves the angiotensin-converting enzyme 2- (ACE2) surface receptors of endothelial cells belonging to various organs which act as the binding site for the viral spike (S) protein of SARS-CoV-2. The COVID-19 virus has been recently listed as a primary risk factor for the following cardiovascular conditions such as pericarditis, myocarditis, arrhythmias, myocardial injury, cardiac arrest, heart failure and coagulation abnormalities in the patients confirmed with COVID-19 viral infection. Direct and indirect type of tissue damage were the two major categories detected with cardiovascular abnormalities. Direct myocardial cell injury and indirect damage to the myocardial cell due to inflammation were clinically reported. Few drugs were clinically administered to regulate the vital biological mechanism along with symptomatic treatment and supportive therapy.<\/jats:p>","DOI":"10.3389\/fcvm.2021.670659","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T04:53:07Z","timestamp":1620881587000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiovascular Impacts on COVID-19 Infected Patients"],"prefix":"10.3389","volume":"8","author":[{"given":"Somasundaram","family":"Raghavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gayathri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar","family":"Kancharla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachetha","family":"Kolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ranjitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalakshmi","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"B1","unstructured":"Disease (COVID-19)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1055\/s-0040-1715094","article-title":"Coronavirus (COVID-19), coagulation, and exercise: interactions that may influence health outcomes","volume":"46","author":"Zadow","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"B3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/CRD0000000000000317","article-title":"The novel coronavirus disease (COVID-19) and its impact on cardiovascular disease","volume":"28","author":"Golemi","year":"2020","journal-title":"Card Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"100557","DOI":"10.1016\/j.ijcha.2020100557","article-title":"Coronavirus disease 2019 and cardiovascular system: a narrative review","volume":"29","author":"Kwenandar","year":"2020","journal-title":"IJC Heart Vascul."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/heartjnl-2020-317258","article-title":"Adult congenital heart disease and the COVID-19 pandemic","volume":"106","author":"Radke","year":"2020","journal-title":"Heart."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.20202648","article-title":"Characteristics of important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Centre for Disease Control Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1001\/jama.20203204","article-title":"Epidemiologic features clinical course of patients infected with SARS-CoV-2 in Singapore","volume":"323","author":"Young","year":"2020","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S2213-2600(20)30161-2","article-title":"Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations","volume":"8","author":"Phua","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamacardio.20201017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s15010-020-01424-5","article-title":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights","volume":"48","author":"Zeng","year":"2020","journal-title":"Infection"},{"key":"B13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00134-015-4141-2","article-title":"Acute or pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, clinical impact","volume":"42","author":"Mekontso","year":"2016","journal-title":"Int Care Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.jcmg.2020.04014","article-title":"Prognostic value of right ventricular longitudinal strain in patients with COVID-19","volume":"13","author":"Li","year":"2020","journal-title":"JACC Cardiovasc Imag."},{"key":"B16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.hjc.2020.05004","article-title":"Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery","volume":"61","author":"Lazaridis","year":"2020","journal-title":"Hellenic J Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.20200950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamacardio.20200934","article-title":"An acute respiratory infection runs into the most common noncommunicable epidemic\u2014COVID-19 and cardiovascular diseases","volume":"5","author":"Yang","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI00127-20","article-title":"Receptor recognition by the Novel Coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS Coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamacardio.20201282","article-title":"Coronavirus disease 2019 (COVID-19) infection and renin angiotensin system blockers","volume":"5","author":"Bavishi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/jcmm12573","article-title":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats","volume":"19","author":"Klimas","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/HJH0b013e32834f04b6","article-title":"FinnDiane Study Group. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications","volume":"30","author":"Soro-Paavonen","year":"2012","journal-title":"J Hypertens"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.RES.87.5e1","article-title":"A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature."},{"key":"B27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1006\/viro.20000757","article-title":"Coronavirus spike proteins in viral entry and pathogenesis","volume":"279","author":"Gallagher","year":"2001","journal-title":"Virology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/scienceabb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science."},{"key":"B31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1101\/2020.01.31929042","article-title":"The novel coronavirus 2019 (2019-NCoV) uses the sars-coronavirus receptor ace2 and the cellular protease TMPRSS2 for entry into target cells","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Mol Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2020.03005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J Adv Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur J Intern Med."},{"key":"B36","first-page":"23","article-title":"Cardiovascular complications of the coronavirus (COVID-19) infection: COVID-19 and the heart","volume":"15","author":"Manolis","year":"2020","journal-title":"Rhythmos"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.20201585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Corona virus Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"Jama."},{"key":"B38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lan Respir Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.120047349","article-title":"Description and proposed management of the acute COVID-19 cardiovascular syndrome","volume":"141","author":"Hendren","year":"2020","journal-title":"Circulation."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1093\/eurheartj\/ehaa286","article-title":"Acute myocarditis presenting as a reverse tako-tsubo syndrome in a patient with SARS-CoV-2 respiratory infection","volume":"41","author":"Sala","year":"2020","journal-title":"Eur Heart J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/jamacardio.20201096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/ejhf1828","article-title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock","volume":"22","author":"Tavazzi","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B43","article-title":"COVID-19 and the heart: insights from the front lines","author":"Wood","year":"","journal-title":"tctMD"},{"key":"B44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/eurheartj\/ehaa190","article-title":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin","volume":"42","author":"Hu","year":"2021","journal-title":"Eur Heart J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Int Care Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/PPO0000000000000035","article-title":"Managing cytokine release syndrome associated with novel T cell-engaging therapies","volume":"20","author":"Maude","year":"2014","journal-title":"Cancer J"},{"key":"B47","unstructured":"SARS coronavirus could cause multi-organ infection\n            ZhaoJ\n            ZhouG\n            SunY\n          Med J Chinese People's Liberation Army1982"},{"key":"B48","unstructured":"Pathological study of impact of SARS coronavirus on heart and its conduction system in SARS patients\n            ZhouG\n            ZhaoJ\n            WangS\n          Med J Chinese People's Liberation Army1982"},{"key":"B49","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur J Clin Invest."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMra0800028","article-title":"Myocarditis","volume":"360","author":"Cooper","year":"2009","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3760\/cma.j.cn112151-20200312-00193","article-title":"A pathological report of three COVID-19 cases by minimally invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B52","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute pulmonary embolism and COVID-19 pneumonia: a random association","volume":"41","author":"Danzi","year":"2020","journal-title":"Eur Heart J"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120046941","article-title":"Coronavirus (COVID-19) and cardiovascular disease","volume":"141","author":"Clerkin","year":"2019","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"773","DOI":"10.20944\/preprints202003.0180v1","article-title":"First case of COVID-19 infection with Fulminant Myocarditis Complication: Case Report and Insights","volume":"48","author":"Zeng","year":"2020","journal-title":"Infection"},{"key":"B56","unstructured":"Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)2020"},{"key":"B57","unstructured":"10.15557\/PiMR.20200003Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected2020"},{"key":"B58","doi-asserted-by":"publisher","first-page":"256294","DOI":"10.1155\/2012\/256294","article-title":"Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","volume":"2012","author":"Tikellis","year":"2012","journal-title":"Int J Pept"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"New Eng J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"m1091","DOI":"10.1136\/bmjm1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0008280","DOI":"10.2139\/ssrn3548785","article-title":"Clinical findings of patients with coronavirus disease 2019 in Jiangsu Province, China: a retrospective, multi-center study","volume":"14","author":"Huang","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/jmv25809","article-title":"Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan","volume":"92","author":"Han","year":"2020","journal-title":"China J Med Virol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.2720028530","article-title":"Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19)","author":"Chen","year":"2020","journal-title":"MedRxiv [Preprint]"},{"key":"B65","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.hjc.2018.03006","article-title":"Hyponatremia is associated with occurrence of atrial fibrillation in outpatients with heart failure and reduced ejection fraction","volume":"60","author":"Cavusoglu","year":"2019","journal-title":"Hellenic J Cardiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4149\/gpb_2012_047","article-title":"Reversible atrial gap junction remodeling during hypoxia\/reoxygenation and ischemia: a possible arrhythmogenic substrate for atrial fibrillation","volume":"31","author":"Severino","year":"2012","journal-title":"Gen Physiol Biophys"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York City","volume":"382","author":"Goyal","year":"2020","journal-title":"N Engl J Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B69","unstructured":"Request for Emergency Use Authorization For Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03024","article-title":"Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic 33 potential of possible pharmacotherapies for coronavirus disease 19 (COVID19)","volume":"95","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B71","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1183\/0905918000001314","article-title":"Overview of current lung imaging in acute respiratory distress syndrome","volume":"23","author":"Zompatori","year":"2014","journal-title":"Eur Respir Rev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1002\/ajh25774","article-title":"Hematologic parameters in patients with COVID-19 infection","volume":"95","author":"Fan","year":"2020","journal-title":"Am J Hematol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2016.06015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int J Infect Dis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"382","author":"Van Doremalen","year":"2020","journal-title":"N Eng J Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1126\/scitranslmedaal3653","article-title":"Broad-spectrum antiviral GS5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3201\/eid1001030404","article-title":"Severe acute respiratory syndrome-associated coronavirus in lung tissue","volume":"10","author":"Mazzulli","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"000878","DOI":"10.1136\/jitc-2020-000878corr1Amendment","article-title":"Insights from immuno-oncology: the Society for Immunotherapy of Cancer statement on access to IL-6-targeting therapies for COVID-19","volume":"8","author":"Ascierto","year":"2020","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.670659\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T04:53:16Z","timestamp":1620881596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.670659\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":79,"alternative-id":["10.3389\/fcvm.2021.670659"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.670659","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"article-number":"670659"}}